Based on this cancer checklist context and NCCN guidelines: CANCER CHECKLIST CONTEXT: Cancer Type: Head & Neck...

Questions to Ask Your Oncologist About Stage IV Head & Neck Cancer

Based on your Stage IV head & neck cancer diagnosis, here are important questions organized by topic to help you have a productive conversation with your oncologist:

About Your Diagnosis & Testing

Understanding Your Cancer:

1. "Can you explain exactly where my cancer started and where it has spread?"
2. "What is the HPV status of my tumor, and how does that affect my treatment options and prognosis?"
3. "What does Stage IV mean specifically for my case - is this IVA, IVB, or IVC?"

Biomarker & Genomic Testing: 4. "Have I had comprehensive genomic profiling (CGP) of my tumor? If not, would this testing help identify targeted therapy options for me?" 5. "Has my tumor been tested for MSI-H (microsatellite instability-high) or dMMR (mismatch repair deficiency)? These can indicate whether immunotherapy might be particularly effective." 6. "What is my PD-L1 expression level, and how does this influence immunotherapy decisions?" 7. "Would liquid biopsy testing be helpful for monitoring my disease or detecting resistance to treatment?" 8. "Should I consider germline (inherited) genetic testing to understand if there are hereditary factors that might affect my treatment or my family's cancer risk?"

According to NCCN Guidelines, comprehensive molecular testing is increasingly important in head & neck cancers to identify actionable mutations and guide treatment selection, particularly in the advanced/metastatic setting.

About Treatment Options

Current Treatment Plan: 9. "What are my treatment options - surgery, radiation, chemotherapy, immunotherapy, targeted therapy, or a combination?" 10. "What is the goal of treatment - cure, control, or symptom management?" 11. "How do you decide between different treatment approaches for my specific situation?" 12. "Are there FDA-approved targeted therapies or immunotherapies that match my tumor's biomarkers?"

Clinical Trials: 13. "Are there clinical trials available that might be appropriate for my cancer type and biomarker profile?" 14. "How do I access information about trials, and would you recommend I consider one?"

About Side Effects & Quality of Life

Managing Treatment Effects: 15. "What are the most common side effects of the recommended treatment?" 16. "How will treatment affect my ability to eat, speak, and swallow?" 17. "What supportive care services are available - speech therapy, nutritional support, pain management?" 18. "Should I meet with a palliative care specialist to help manage symptoms?" (Note: Palliative care helps with symptom management at any stage, not just end-of-life care)

About Monitoring & Follow-Up

Tracking Your Response: 19. "How will we know if treatment is working?" 20. "How often will I have scans or other tests to monitor my cancer?" 21. "What symptoms should I watch for that would require immediate attention?" 22. "If this treatment stops working, what are the next-line options?"

About Practical Matters

Logistics & Support: 23. "How long will treatment last, and what is the schedule?" 24. "What should I do to prepare for treatment?" 25. "Are there support groups or resources for head & neck cancer patients you recommend?" 26. "Should I get a second opinion, and can you help facilitate that?"

About Advanced Testing Options

Based on emerging evidence, you might also ask:

1. "Would circulating tumor DNA (ctDNA) testing help monitor minimal residual disease or detect recurrence earlier?"
2. "Are there any emerging biomarkers specific to head & neck cancer that I should be tested for?"
3. "How frequently should biomarker testing be repeated, especially if my cancer progresses?"

---

Why These Questions Matter

Comprehensive Genomic Profiling can identify specific mutations (like PIK3CA, HRAS, or FGFR alterations) that may be targetable with specific therapies. According to NCCN Guidelines, molecular testing is increasingly recommended to guide treatment decisions in advanced head & neck cancers.

MSI/MMR Testing is important because MSI-high tumors often respond very well to immunotherapy drugs like pembrolizumab, which has FDA approval for MSI-high solid tumors regardless of where the cancer started.

PD-L1 Expression helps predict response to immunotherapy agents, which have become important treatment options in head & neck cancer, particularly in the recurrent or metastatic setting.

Germline Testing may be recommended if you have certain risk factors or family history, as inherited mutations can sometimes influence treatment selection and have implications for family members.

---

Tips for Your Appointment

• Bring someone with you to take notes and help remember information
• Write down your questions beforehand and prioritize the most important ones
• Ask for clarification if you don't understand something - say "Can you explain that in simpler terms?"
• Request copies of all test results and pathology reports
• Take notes or ask if you can record the conversation (with permission)
• Don't rush - if you need more time to discuss, ask to schedule a follow-up appointment

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions. Your oncologist knows your complete medical history and can provide guidance specific to your individual situation. These questions are designed to help you engage in shared decision-making about your care.